CAAS Capital Management’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,000
| Closed | -$1K | – | 279 |
|
|
2024
Q4 | $1K | Hold |
10,000
| – | – | ﹤0.01% | 103 |
|
|
2024
Q3 | $707 | Hold |
10,000
| – | – | ﹤0.01% | 93 |
|
|
2024
Q2 | $870 | Hold |
10,000
| – | – | ﹤0.01% | 71 |
|
|
2024
Q1 | $1.6K | Hold |
10,000
| – | – | ﹤0.01% | 112 |
|
|
2023
Q4 | $808 | Buy |
+10,000
| New | +$808 | ﹤0.01% | 134 |
|
|
2023
Q3 | – | Sell |
-10,000
| Closed | -$2K | – | 464 |
|
|
2023
Q2 | $2K | Hold |
10,000
| – | – | ﹤0.01% | 196 |
|
|
2023
Q1 | $1.4K | Hold |
10,000
| – | – | ﹤0.01% | 276 |
|
|
2022
Q4 | $849 | Hold |
10,000
| – | – | ﹤0.01% | 430 |
|
|
2022
Q3 | $2K | Hold |
10,000
| – | – | ﹤0.01% | 432 |
|
|
2022
Q2 | $3K | Hold |
10,000
| – | – | ﹤0.01% | 440 |
|
|
2022
Q1 | $6K | Hold |
10,000
| – | – | ﹤0.01% | 316 |
|
|
2021
Q4 | $12K | Buy |
+10,000
| New | +$12K | ﹤0.01% | 397 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 550 |
|